Response to Letter Regarding Article, “Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation”
Author(s) -
Lars Wallentin,
Renato D. Lópes,
Michael Hanna,
Laine Thomas,
Anne S. Hellkamp,
Sunil Nepal,
Elaine M. Hylek,
Sana M. AlKhatib,
John H. Alexander,
Marco Alings,
John Amerena,
Jack Ansell,
Philip E. Aylward,
Jozef Bartúnek,
Patrick Commerford,
Raffaele De Caterina,
Çetin Erol,
Veli-Pekka Harjola,
Claes Held,
John D. Horowitz,
Kurt Huber,
Steen Husted,
Matyàs Keltai,
Fernando Laņas,
Lisheng Liu,
John J.V. McMurray,
ByungHee Oh,
Mårten Rosenqvist,
Witold Rużyłło,
Philippe Gabríel Steg,
Dragoş Vinereanu,
Denis Xavier,
Christopher B. Granger
Publication year - 2014
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.113.005709
Subject(s) - medicine , apixaban , atrial fibrillation , warfarin , rivaroxaban
Lars Wallentin ... John Horowitz ... et al
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom